Alan Lewis, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 22,500 shares at $56.57 ($1.3M) on 2013-02-27, disclosed to the SEC on 2013-02-28.
Open-market sale of $1.3M BMRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BMRN | SELL | 2014-12-08 | $674K | — | Filing → |
| BMRN | SELL | 2013-12-11 | $1.6M | — | Filing → |
| BMRN | SELL | 2012-11-09 | $702K | — | Filing → |